Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AKAP8L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC9A3R2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ANPEP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PEX19 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRIA3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IVD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EHD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PARVB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IGFBP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRPF40A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CLTC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRMT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NEUROG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
CES2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDK7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GLIPR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CD63 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GSTCD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NMU - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on